Sudeep Pharma IPO: ₹895 Cr Offer Opens, ₹130 Grey Market Premium
Sudeep Pharma's ₹895 crore IPO opens with ₹563-593 price band. Grey market shows ₹130 premium. Analysts recommend long-term investment for 2-5 years horizon.
Category : Search result: pharmaceutical firms
Sudeep Pharma IPO: ₹895 Crore Offer Opens Today
Sudeep Pharma's ₹895 crore IPO opens today. Price band ₹563-593 per share. Learn about company details, investment minimums & global presence. Subscribe now!
India Sends 3.5 Tonnes Medical Aid to Seychelles
India strengthens ties with Seychelles by delivering 3.5 tonnes of essential medicines. This humanitarian gesture showcases India's commitment to global health partnerships.
Automation Hits India Tech Hiring, Staffing Firms Suffer
Global capability centers in India are cutting routine hiring due to automation and weak IT demand, squeezing revenues at major staffing firms while specialized roles see growth.
Sudeep Pharma IPO: 22% GMP, Opens Nov 21
Sudeep Pharma's ₹95 crore IPO opens November 21 with strong grey market premium. Learn price band, dates, financials & investment details for this pharma ingredients maker.
Sudeep Pharma IPO: ₹895 Cr Issue Opens Nov 21
Sudeep Pharma's ₹895 crore IPO opens November 21-25. Price band ₹563-593 per share. Company manufactures pharmaceutical excipients and speciality ingredients.
ED Probes Gaming Firms' Crypto Money Laundering
Enforcement Directorate investigation reveals gaming promoters using cryptocurrency wallets for money laundering. Search operations uncover digital financial crimes.
DPDP Rules: Large Firms May Face 2025 Compliance Deadline
Indian government considers accelerating DPDP Act compliance for major corporations. Learn how this impacts data protection and business operations in India.
Remedium Lifecare Q2 Profit Jumps 92% to ₹38.62 Cr
Remedium Lifecare reports stellar Q2 results with profit nearly doubling to ₹38.62 crore. Revenue surges 22% driven by strong pharmaceutical exports and domestic growth.
Evexia Lifecare Share Price Rises 3% on High Volumes
Evexia Lifecare share price gained over 3% with heavy trading volumes. Discover the Q2 FY26 results showing a sharp profit fall and the stock's long-term decline. Read analysis before investing.
Novo Nordisk brings back former CEO as chairman
Lars Rebien Sorensen returns as Novo Nordisk chairman after board shakeup. The move follows Pfizer's $10B Metsera acquisition, intensifying obesity drug competition.
Hvax Technologies H1 FY26 Income Jumps 35%
Hvax Technologies announces impressive 35% growth in total income for H1 FY26, reaching ₹5.95 crore. The company shows strong financial performance with significant profit improvements.
Punjab Health Minister's Stern Warning to Drug Manufacturers
Punjab Health Minister Dr Balbir Singh issues strict quality warning to drug manufacturers after MP cough syrup incident. State adopts zero-tolerance policy on sub-standard medicines.
India Urges Russia to Fast-Track Export Approvals
India requests Russia to expedite approvals for Indian exporters in marine, pharmaceutical sectors during Moscow talks. Bilateral trade targets $100B by 2030. Key discussions ahead of Putin's December visit.
FSSAI bans misleading ORS ads, FDC's Electral validated
FSSAI cracks down on false ORS marketing claims. FDC Ltd welcomes action, reaffirming Electral's 50-year scientific legacy as genuine electrolyte solution.
Lincoln Pharma Aims for Rs 1000 Crore Revenue
Lincoln Pharmaceuticals Ltd announces ambitious plan to achieve Rs 1000 crore revenue within three years through strategic expansion and new product launches. Read more about their growth strategy.
India Pushes Russia for Faster Approvals to Boost Trade
India urges Russia to expedite approvals for marine and pharmaceutical products during Moscow talks. Bilateral trade currently at $25 billion, targeting $100 billion by 2030.
Bry-Air Launches P80X MOF Dehumidifier for Pharma
Bry-Air introduces P80X, the most advanced MOF-technology dehumidifier for pharmaceutical manufacturing. Ensures precise humidity control for quality compliance.
Gujarat Pharma Factory Blast: 2 Dead, 20 Injured
Tragic boiler explosion at pharmaceutical factory in Bharuch's Saykha GIDC leaves 2 workers dead, 20 injured. Fire brigade and investigation teams on site. Read latest updates.
Gujarat Pharma Factory Blast: 2 Dead, 20 Injured
Tragic boiler explosion at pharmaceutical factory in Gujarat's Bharuch district claims 2 lives, leaves 20 injured. Massive fire brought under control by emergency teams.
FDA Names Dr. Richard Pazdur as New Drug Center Director
The FDA appoints veteran cancer regulator Dr. Richard Pazdur to lead its drug center following the ouster of Dr. George Tidmarsh over ethics concerns. Learn about the challenges ahead.
Granules India Gets USFDA Approval for Hyderabad Plant
Granules Life Sciences receives USFDA approval for new Hyderabad facility to manufacture diabetes drug Metformin HCL. Capacity: 10 billion tablets annually. Read more about this pharmaceutical milestone.
Ultra-Rare Recessions Store Up Future Economic Trouble
The world economy hasn't seen a synchronized recession in 15 years, but this stability creates financial, fiscal and allocative risks. Learn why rare downturns threaten economic health.
Indian Pharma Units Face Closure Over GMP Non-Compliance
DCGI directs state authorities to enforce strict GMP compliance by December 31, 2025. Delhi, Himachal Pradesh, Uttarakhand already taking action against non-compliant manufacturers.
DCGI Orders Global Pharma Standards Implementation by Jan 2026
India's drug regulator DCGI mandates global manufacturing standards for all pharma companies by January 2026. State regulators ordered to begin inspections immediately. Read about the strict compliance requirements.
Sun Pharma: US Tariff Clarity & Q2 FY26 Outlook
Sun Pharma investors await Q2 FY26 results with cautious optimism as US tariff clarity emerges. Discover how import duties and market dynamics could impact India's pharmaceutical giant.
Curis Lifesciences IPO: 17x Subscription on Day 1
Curis Lifesciences' NSE SME IPO witnesses massive investor response with 17.36 times subscription on Day 1. Discover GMP trends, price band details, and why this pharma stock is creating buzz.
Pharma Executive Collapses in Oval Office During Trump Meeting
A high-stakes White House meeting on weight-loss drug prices took a dramatic turn when a pharmaceutical executive suddenly collapsed, forcing an abrupt end to Donald Trump's briefing. The viral video has sparked nationwide concern.
Trump: Deal Reached to Lower Weight Loss Drug Prices
Former President Donald Trump reveals groundbreaking agreement with pharmaceutical giants to dramatically reduce costs of popular weight loss medications, promising relief for millions struggling with obesity.
Big Pharma Cuts Obesity Drug Prices After Trump Pressure
In a major victory for American patients, pharmaceutical titans Eli Lilly and Novo Nordisk announce significant price reductions for popular weight-loss medications after Trump's intervention.
Page 2 of 4